Aclarion Reports Nearly 100 Nociscan Procedures at The London Clinic, Signaling Growing Adoption for Chronic Low Back Pain Evaluation

Aclarion announced that nearly 100 Nociscan procedures have been performed at The London Clinic, highlighting increased physician adoption of the non-invasive diagnostic tool for chronic low back pain, as featured in a new video with lead clinician Mr. John Sutcliffe.

SD Metrowire Staff
Healthcare
Aclarion Reports Nearly 100 Nociscan Procedures at The London Clinic, Signaling Growing Adoption for Chronic Low Back Pain Evaluation

Aclarion, Inc. (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company, announced today that nearly 100 Nociscan procedures have been performed at The London Clinic, one of the United Kingdom's leading private hospitals. The milestone reflects growing adoption of the non-invasive diagnostic tool for evaluating chronic low back pain. To highlight real-world physician experience, the company released a video featuring Mr. John Sutcliffe, Consultant Spinal Neurosurgeon and Lead Clinician at The London Spine Clinic.

With over 30 years of experience treating spinal conditions, Mr. Sutcliffe shared his perspective on integrating Nociscan into clinical practice. “Nociscan provides an additional layer of insight that complements traditional imaging,” he said. “Having more objective data can help inform clinical decisions and improve confidence when evaluating patients with chronic low back pain.” The video is available here.

Nociscan leverages magnetic resonance spectroscopy (MRS) and proprietary signal processing to identify chemical biomarkers associated with disc pain. It helps physicians differentiate between painful and non-painful discs in the lumbar spine, offering a non-invasive solution for a condition affecting approximately 266 million people worldwide. Clinical data has demonstrated up to a 97% surgical success rate when all Nociscan-positive discs are treated alongside other diagnostic tools.

“This video offers a compelling perspective on how Nociscan is being used in day-to-day clinical practice,” said Brent Ness, Chief Executive Officer of Aclarion. “Approaching 100 scans at a leading international center like The London Clinic is an important indicator of increasing adoption and reinforces the potential for Nociscan to become a valuable tool in the evaluation of chronic low back pain.”

The continued use of Nociscan at The London Clinic reflects sustained physician engagement and growing integration into routine clinical practice. For more information, visit the company's newsroom at https://tinyurl.com/aconnewsroom. To find a Nociscan center, view the site map here.

Blockchain Registration

QR Code for Blockchain Registration